|
|
 |
| |
|
Home > Drug Companies > Shire US Inc.
Shire US Inc.
A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.
Shire was established and funded in 1986 in the UK by four entrepreneurs. Each had considerable experience either in or directly serving the pharmaceutical industry. The company, initially launched and sold a range of calcium products designed to help with the bone disease, osteoporosis. The company, originally named AimCane, began in a small office above a shop in Hampshire in the UK. The company soon changed its name to Shire which came from the name of the building that housed the company in those early days.
Shire is a rapidly growing global specialty pharmaceutical company.The Group has a global sales and marketing infrastructure with a broad portfolio of products and its own direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. The Company also covers the other significant pharmaceutical markets indirectly through distributors. Shire’s interest in the Pacific Rim is managed through Shire’s regional office based in Singapore.
Shire already has a wide range of products on the market and continues to use their search and development expertise to ensure that it can make more products available for these medically challenging diseases in the future.
The Company has a strategic focus on meeting the needs of the specialist physician and currently focuses on developing projects and marketing products in the areas of central nervous system, gastrointestinal, and renal diseases. This enables them to gain considerable expertise in these areas and build long term relationships with specialist prescribers.
Back to Drug Companies
|
|
|
|
|
|
|
|